Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight
October 17, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight The Ebola virus market is focused on...
New Zealand Colocation Center Portfolio 2024: Detailed Analysis of 30 Existing and 8 Upcoming Data Centers with Coverage of 19 Investors/Operators
October 17, 2024 10:26 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "New Zealand Existing & Upcoming Data Center Portfolio" report has been added to ResearchAndMarkets.com's offering. Auckland dominates the...
Epilepsy Foundation Welcomes New Chief Financial Officer
October 16, 2024 12:05 ET
|
Epilepsy Foundation
The Epilepsy Foundation announced today the appointment of Wanda Cook as the new chief financial officer.
Valneva and LimmaTech reçoivent le statut « Fast Track » de la FDA pour leur candidat vaccin tétravalent contre la Shigellose S4V
October 16, 2024 11:45 ET
|
VALNEVA
Saint Herblain (France) et Schlieren (Zurich), le 16 octobre 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, et LimmaTech Biologics AG, société de...
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
October 16, 2024 11:45 ET
|
VALNEVA
Saint Herblain (France) and Schlieren (Zurich), October 16, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech...
Australia Data Center Colocation Supply & Demand Analysis 2024: Market is Currently Witnessing the Entry of New Operators such as Trifalga, Supernode, Vantage, GreenSquareDC - Forecast to 2029
October 16, 2024 11:15 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Australia Data Center Colocation Market - Supply & Demand Analysis 2024-2029" report has been added to ResearchAndMarkets.com's offering.The...
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress
October 16, 2024 08:30 ET
|
Veru Inc.
MIAMI, FL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
Monkeypox Diagnostics Market by Assay, Country, Product, and Place with Executive & Consultant Guides and Analysis & Forecasts
October 16, 2024 05:54 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts"...
Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update
October 16, 2024 01:00 ET
|
BioVersys
BV100 Phase 2 preliminary results suggest BV100 is generally safe and well tolerated and showed strong initial signs of efficacy in VABP patientsStrategic investment from GIBF and launch of...
Hyaluronic Acid Market Driven by Increasing Demand for Cosmetics and Expected to Grow over 21 Bn by 2032
October 16, 2024 00:00 ET
|
IMIR Market Research Pvt. Ltd.
Gondia, India, Oct. 16, 2024 (GLOBE NEWSWIRE) -- In 2023, the Hyaluronic Acid market size was valued at USD 10,475.99 Million and is expected to reach USD 21,543.23 Million at the CAGR of 7.3%...